Annual Interest Coverage Ratio
-127.71
+138.52+52.03%
December 31, 2023
Summary
- As of February 23, 2025, VRDN annual interest coverage ratio is -127.71, with the most recent change of +138.52 (+52.03%) on December 31, 2023.
- During the last 3 years, VRDN annual interest coverage ratio has risen by +89.23 (+41.13%).
- VRDN annual interest coverage ratio is now -127610.00% below its all-time high of -0.10, reached on December 31, 2013.
Performance
VRDN Interest Coverage Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Coverage Ratio
-75.38
+32.49+30.12%
September 30, 2024
Summary
- As of February 23, 2025, VRDN quarterly interest coverage ratio is -75.38, with the most recent change of +32.49 (+30.12%) on September 30, 2024.
- Over the past year, VRDN quarterly interest coverage ratio has stayed the same.
- VRDN quarterly interest coverage ratio is now -13560.71% below its all-time high of 0.56, reached on December 31, 2013.
Performance
VRDN Quarterly Interest Coverage Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Coverage Ratio Formula
Interest Coverage Ratio = EBIT
Interest Expense
EBIT
Interest Expense
Interest Expense
VRDN Interest Coverage Ratio Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +52.0% | 0.0% |
3 y3 years | +41.1% | 0.0% |
5 y5 years | -250.3% | 0.0% |
VRDN Interest Coverage Ratio Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +99.5% | -4.7% | +99.2% |
5 y | 5-year | -159.8% | +99.5% | -34.5% | +99.2% |
alltime | all time | <-9999.0% | +99.5% | <-9999.0% | +99.2% |
Viridian Therapeutics Interest Coverage Ratio History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -75.38(-30.1%) |
Jun 2024 | - | -107.87(+32.0%) |
Mar 2024 | - | -81.70(+13.5%) |
Dec 2023 | -127.71(-52.0%) | -71.99(-8.2%) |
Sep 2023 | - | -78.43(-76.3%) |
Jun 2023 | - | -330.70(-19.7%) |
Mar 2023 | - | -412.04(+51.7%) |
Dec 2022 | -266.23(-99.0%) | -271.53(+54.9%) |
Sep 2022 | - | -175.25(-8.0%) |
Jun 2022 | - | -190.50(-98.0%) |
Dec 2021 | -26.47 K(>+9900.0%) | -9647.67(+1817.6%) |
Dec 2020 | -216.94(+341.4%) | -503.12(+766.3%) |
Sep 2020 | - | -58.08(-13.9%) |
Jun 2020 | - | -67.46(+20.4%) |
Mar 2020 | - | -56.05(-4.2%) |
Dec 2019 | -49.15(+34.8%) | -58.52(+8.3%) |
Sep 2019 | - | -54.05(+42.8%) |
Jun 2019 | - | -37.85(-23.0%) |
Mar 2019 | - | -49.13(+11.0%) |
Dec 2018 | -36.46 | -44.25(+11.8%) |
Sep 2018 | - | -39.59(-0.3%) |
Jun 2018 | - | -39.72(+86.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2018 | - | -21.30(-34.7%) |
Dec 2017 | -68.22(-48.5%) | -32.61(-67.3%) |
Sep 2017 | - | -99.59(-12.1%) |
Jun 2017 | - | -113.25(+16.4%) |
Mar 2017 | - | -97.31(-54.4%) |
Dec 2016 | -132.41(+66.9%) | -213.23(+170.0%) |
Sep 2016 | - | -78.96(-26.9%) |
Jun 2016 | - | -108.00(-9.2%) |
Mar 2016 | - | -118.91(-7.5%) |
Dec 2015 | -79.34(+1082.4%) | -128.57(-1.4%) |
Sep 2015 | - | -130.33(+276.9%) |
Jun 2015 | - | -34.58(-70.9%) |
Mar 2015 | - | -118.73(-89.5%) |
Dec 2014 | -6.71(+6610.0%) | -1128.00(+176.3%) |
Sep 2014 | - | -408.25(+6843.0%) |
Jun 2014 | - | -5.88(+1796.8%) |
Mar 2014 | - | -0.31(-155.4%) |
Dec 2013 | -0.10(-96.0%) | 0.56(-201.8%) |
Sep 2013 | - | -0.55(+323.1%) |
Jun 2013 | - | -0.13(-23.5%) |
Mar 2013 | - | -0.17 |
Dec 2012 | -2.53 | - |
FAQ
- What is Viridian Therapeutics annual interest coverage ratio?
- What is the all time high annual interest coverage ratio for Viridian Therapeutics?
- What is Viridian Therapeutics annual interest coverage ratio year-on-year change?
- What is Viridian Therapeutics quarterly interest coverage ratio?
- What is the all time high quarterly interest coverage ratio for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly interest coverage ratio year-on-year change?
What is Viridian Therapeutics annual interest coverage ratio?
The current annual interest coverage ratio of VRDN is -127.71
What is the all time high annual interest coverage ratio for Viridian Therapeutics?
Viridian Therapeutics all-time high annual interest coverage ratio is -0.10
What is Viridian Therapeutics annual interest coverage ratio year-on-year change?
Over the past year, VRDN annual interest coverage ratio has changed by +138.52 (+52.03%)
What is Viridian Therapeutics quarterly interest coverage ratio?
The current quarterly interest coverage ratio of VRDN is -75.38
What is the all time high quarterly interest coverage ratio for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly interest coverage ratio is 0.56
What is Viridian Therapeutics quarterly interest coverage ratio year-on-year change?
Over the past year, VRDN quarterly interest coverage ratio has changed by 0.00 (0.00%)